Answers are grounded in this paper and cite their sources.
Host cell proteins (HCPs) complicate the purification of recombinant proteins produced in Chinese hamster ovary (CHO) cells, but most mechanistic knowledge derives from monoclonal antibody processes. This review examines how that knowledge applies to His-tagged proteins purified by immobilized metal affinity chromatography (IMAC). Secreted products and membrane-associated products enter purification through different routes, with extracellular release dominating the former and fractionation and co-extraction shaping the latter. HCP priorities are assessed from evidence of a relevant harmful effect, persistence or activity, and intended use. Four overlapping retention routes are considered: metal coordination, support or ligand adsorption, target association, and carriage within multicomponent assemblies. Direct CHO/IMAC studies address capture and process-level HCP reduction, whereas antibody and other-host studies provide mechanistic precedents requiring evaluation in the intended matrix. We distinguish product recovery from impurity clearance and relate analytical findings to feed preparation, chromatography, and selected upstream interventions. Particular attention is given to detergent- and lipid-containing preparations, for which solubility, association state, and analytical recovery can change together. The available evidence supports impurity-specific control linked to product quality, while highlighting the need for direct studies of individual HCPs in CHO/IMAC processes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: